CJC-1295 no DAC 10mg

All compounds and related materials are supplied as a complete research package and are provided strictly for laboratory research use only. This includes all necessary related materials (such as bacteriostatic water, syringes, and accessories) for research preparation. They are not intended for human or veterinary use, medical diagnosis, treatment, or any form of self-administration.

CJC-1295 no DAC 10 mg – Research Peptide for Growth Hormone Release Studies

CJC-1295 no DAC (also known as MOD GRF 1-29) is a short-acting analog of growth hormone-releasing hormone (GHRH), designed for precise, pulse-based GH stimulation. Unlike CJC-1295 with DAC, this form does not bind to serum albumin, resulting in shorter activity and sharper hormone release peaks — highly valuable for mechanistic GH research. Supplied as a lyophilized (freeze-dried) peptide to preserve full integrity during controlled laboratory handling.

Historical Background and Scientific Context

Originally developed in the 1990s as a modified fragment of GHRH (1-29), CJC-1295 no DAC was engineered to resist rapid enzymatic degradation and support short-term hormone pulse studies. Between 2005 and 2024, MOD GRF (1-29) became a core research compound in neuroendocrine and metabolic investigations focusing on GH/IGF-1 axis modulation and pituitary feedback response models.

Mechanistic Focus in Research

Within scientific research, CJC-1295 no DAC is examined for its ability to trigger physiological GH release in short bursts through direct GHRH receptor binding. Laboratory studies investigate its role in pituitary signaling, GH pulsatility, and synergy with GHRPs such as Ipamorelin or GHRP-2. Its rapid kinetic profile makes it ideal for precise dose-response and secretion curve analysis.

Analytical Verification (COA)

Laboratory: Liquilabs s.r.o., Czechia
Batch Number: GF102025049
Date Published: 12 October 2025
Identity (RT): 0.994 ± 0.005 confirmed by spectrum (997 ± 10)
Content: 10.88 mg ± 0.05 mg per vial
Purity: ≥ 99.8 %
Bioburden: Not detected (USP <61>)
Endotoxin: < 0.001 EU/mg (USP <85>)
Heavy Metals: Not detected (As, Pb, Cd, Hg, Ni, Co, V)

Research Applications

– Mechanistic GH pulse release investigations
– Endocrine and pituitary feedback studies
– Short-acting peptide stability and half-life experiments
– Combined studies with GHRPs for comparative analysis

Grail Formula Quality – From 24PEPTIDES

Every Grail Formula peptide is independently verified by Liquilabs for identity, purity and safety. Each batch is fully traceable and documented for research-grade reproducibility. All products are supplied as lyophilized powders to ensure maximum stability and consistency.

When you choose Grail Formula CJC-1295 no DAC 10 mg…

…you receive a research-verified compound with ≥ 99.8 % purity and documented analytical identity. Delivered as a complete research package — everything included to initiate your studies immediately in a controlled laboratory environment.

⚠ Research Use Only

This compound and all related materials are intended solely for scientific and laboratory research. They are not approved for diagnostic or therapeutic use and must not be self-administered. Always handle with appropriate protective equipment and follow institutional safety protocols.

High-purity CJC-1295 no DAC (≥ 99.8 %)

COA verified by Liquilabs s.r.o. (Czechia)

Lyophilized powder for long-term stability

Free from microbial contamination and endotoxins

Heavy metals not detected

Delivered as a complete research package

For research use only

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.